Related Experiment Videos
Antidepressant use in clinical practice: efficacy v. effectiveness
1School of Pharmacy and Chemistry, Liverpool John Moores University, Liverpool, UK. john@donoghue.u-net.com
The British Journal of Psychiatry. Supplement
|September 5, 2001
Summary
Real-world antidepressant use significantly impacts treatment effectiveness. Selective serotonin reuptake inhibitors are more often prescribed at adequate doses and durations than tricyclic antidepressants, potentially improving clinical outcomes.
Area of Science:
- Pharmacology
- Clinical Psychiatry
- Treatment Efficacy
Background:
- Antidepressant efficacy is established in controlled trials.
- Real-world effectiveness depends on clinical practice patterns.
- Understanding prescribing habits is crucial for patient outcomes.
Purpose of the Study:
- To assess the frequency of adequate antidepressant dosing and duration in clinical practice.
- To explore the impact of prescribing patterns on symptom remission and relapse prevention.
- To discuss implications for clinical outcomes and real-world efficacy.
Main Methods:
- Review of naturalistic studies on antidepressant prescribing.
- Comparative analysis of antidepressant classes and individual drugs.
- Examination of dose and duration of treatment in routine care.
Main Results:
- Tricyclic antidepressants (TCAs) are frequently prescribed at sub-therapeutic doses and inadequate durations.
- Selective serotonin reuptake inhibitors (SSRIs) are more commonly used with adequate dose and duration.
- Prescribing patterns vary significantly between different antidepressant classes.
Conclusions:
- Clinical practice significantly influences antidepressant effectiveness.
- SSRIs may offer better real-world efficacy due to more optimal prescribing.
- Improving prescribing patterns can enhance patient outcomes and real-world antidepressant efficacy.